Detail akcie RaySearch Lab -B- online

Business Summary: RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, RaySearch Laboratories AB (publ) revenues increased 13% to SEK1.34B. Net income increased 12% to SEK227.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Other operating expenses increase from SEK29.5M to SEK270.4M (expense), Operating Exchange Gain decrease of 76% to SEK10.2M (income).